Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Publication year range
2.
J Clin Anesth ; 35: 430-433, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27871570

ABSTRACT

Carditis can complicate Lyme disease in an estimated <5% of cases, and cardiogenic shock and severe cardiac arrhythmias are described with electrocardiographic abnormalities that could be suggestive of coronary manifestations. We report a case of severe persistent biventricular heart failure complicated by cardiac arrhythmias as initial manifestation of a Lyme disease developing peroperatively electrocardiographic abnormalities suggesting acute transmural myocardial infarction.


Subject(s)
Acute Coronary Syndrome , Lyme Disease/complications , Myocarditis/complications , Myocarditis/microbiology , Shock, Cardiogenic/complications , Shock, Cardiogenic/microbiology , Arrhythmias, Cardiac/complications , Arrhythmias, Cardiac/microbiology , Diagnosis, Differential , Humans , Male , Middle Aged , Perioperative Period
3.
Bull Soc Belge Ophtalmol ; (322): 27-32, 2013.
Article in English | MEDLINE | ID: mdl-24923079

ABSTRACT

We report the case of a 66-year-old woman with visual loss due to anterior ischaemic optic neuropathy. The diagnosis of giant cell arteritis was made on the basis of classic clinical characteristics and haematological abnormalities. Despite corticosteroid treatment, involvement of the other eye occured, resulting in a bilateral and permanent loss of vision. The follow-up was marked by two relapses within the 6 months after the first episode. In order to prevent blindness, ophthalmologists should be familiar with this disorder and should actively participate in the treatment, not leaving the internist deciding alone about tapering corticotherapy.


Subject(s)
Giant Cell Arteritis/diagnosis , Adrenal Cortex Hormones/therapeutic use , Aged , Blindness/etiology , Female , Giant Cell Arteritis/complications , Giant Cell Arteritis/drug therapy , Humans , Practice Patterns, Physicians' , Recurrence
4.
Auton Autacoid Pharmacol ; 32(1 Pt 2): 1-7, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21843205

ABSTRACT

In cardiac surgery, agents are needed to produce temporary cardiac arrest (cardioplegia). One of these agents is esmolol (ESM) which is a short-acting selective beta-1 adrenergic receptor antagonist and its overdose causes diastolic ventricular arrest. The (25) MgPMC(16) (porphyrin adducts of cyclohexil fullerene-C60) is known as a nanoparticle which has a cardioprotective effect when the heart is subjected to stressful conditions. In this study, we aimed to confirm the deleterious effects of ESM overdose on cardiac mitochondria and identify any protective effects of (25) MgPMC(16) in male Wistar rats. Esmolol 100 mg kg(-1) (LD50 = 71 mg kg(-1) ) was injected intravenously (i.v.) into tail vein to induce cardiac arrest. This dose was obtained from an ESM dose-response curve which induces at least 80% arrest in rats. (25) MgPMC(16) at three different doses (45, 90 and 224 mg kg(-1) ) was injected i.v. as pretreatment, eight hours before ESM injection. (25) MgCl(2) or (24) MgPMC(16) were used as controls. Following cardiac arrest, the heart was removed and the mitochondria extracted. Mitochondrial viability and the adenosine 5'-diphosphate sodium salt hydrate/Adenosine 5'-triphosphate disodium salt hydrate (ADP/ATP) ratio were measured as biomarkers of mitochondrial function. Results indicate that (25) MgPMC(16) caused a significant increase in mitochondrial viability and decrease in ADP/ATP ratio. No significant changes were seen with (24) MgPMC(16) or (25) MgCl(2) . It is concluded that cardiac arrest induced by ESM overdose leads to a significant decrease in mitochondrial viability and their ATP levels, whereas pretreatment by (25) MgPMC(16) can protect mitochondria by increasing ATP level through liberation of Mg into cells and the improvement of hypoxia.


Subject(s)
Heart Arrest/prevention & control , Magnesium/therapeutic use , Metal Nanoparticles , Mitochondrial Diseases/prevention & control , Porphyrins/pharmacology , Propanolamines/toxicity , Animals , Cardiotonic Agents/pharmacology , Cardiotonic Agents/therapeutic use , Cell Survival/drug effects , Cell Survival/physiology , Heart Arrest/chemically induced , Heart Arrest/metabolism , Isotopes , Magnesium/metabolism , Male , Metal Nanoparticles/therapeutic use , Mitochondrial Diseases/metabolism , Mitochondrial Diseases/pathology , Porphyrins/therapeutic use , Random Allocation , Rats , Rats, Wistar
5.
Int J Nanomedicine ; 6: 855-62, 2011.
Article in English | MEDLINE | ID: mdl-21720498

ABSTRACT

Silver has been used as an antimicrobial agent for a long time in different forms, but silver nanoparticles (nanosilver) have recently been recognized as potent antimicrobial agents. Although nanosilver is finding diverse medical applications such as silver-based dressings and silver-coated medical devices, its dermal and systemic toxicity via dermal use has not yet been identified. In this study, we analyzed the potential toxicity of colloidal nanosilver in acute and subchronic guinea pigs. Before toxicity assessments, the size of colloidal nanosilver was recorded in sizes <100 nm by X-ray diffraction and transmission electron microscopy. For toxicological assessments, male guinea pigs weighing 350 to 400 g were exposed to two different concentrations of nanosilver (1000 and 10,000 µg/mL) in an acute study and three concentrations of nanosilver (100, 1000, and 10,000 µg/mL) in a subchronic study. Toxic responses were assessed by clinical and histopathologic parameters. In all experimental animals the sites of exposure were scored for any type of dermal toxicity and compared with negative control and positive control groups. In autopsy studies during the acute test, no significant changes in organ weight or major macroscopic changes were detected, but dose-dependent histopathologic abnormalities were seen in skin, liver, and spleen of all test groups. In addition, experimental animals subjected to subchronic tests showed greater tissue abnormalities than the subjects of acute tests. It seems that colloidal nanosilver has the potential to provide target organ toxicities in a dose- and time-dependent manner.


Subject(s)
Nanostructures/toxicity , Silver/toxicity , Skin/drug effects , Animals , Colloids , Dose-Response Relationship, Drug , Guinea Pigs , Histocytochemistry , Inflammation , Liver/drug effects , Liver/pathology , Male , Microscopy, Electron, Transmission , Nanostructures/administration & dosage , Particle Size , Silver/administration & dosage , Skin/pathology , Spleen/drug effects , Spleen/pathology , Toxicity Tests, Acute , X-Ray Diffraction
6.
J Fr Ophtalmol ; 34(6): 384.e1-5, 2011 Jun.
Article in French | MEDLINE | ID: mdl-21492958

ABSTRACT

Ocular recurrences of congenital toxoplasmosis usually occur during the first and second decades of life. At that time, serum levels of IgG against toxoplasmosis are almost always detectable because of the very high sensitivity of the test. The diagnosis is mainly supported by the ophthalmological examination and the good clinical response to treatment. In atypical cases, the Goldman-Witmer coefficient (GWC) on aqueous and polymerase chain reaction (PCR) on aqueous or vitreous is usually performed to substantiate the diagnosis. We report a case of recurrent macular chorioretinitis in a 13-year-old immunocompetent patient with a history of congenital toxoplasmosis whose repeated serologies remained negative or uncertain. However, the diagnosis of toxoplasmic chorioretinitis was supported by the detection of Toxoplasma gondii DNA by PCR analysis in a vitreous sample. Although the sensitivity of serology is very high, it is not perfect and there are false-negative results. In case of high clinical presumption in spite of a negative serology, PCR could be a helpful contribution to the diagnosis.


Subject(s)
Chorioretinitis/parasitology , DNA, Protozoan/analysis , Toxoplasma/isolation & purification , Toxoplasmosis, Ocular/diagnosis , Vitreous Body/parasitology , Adolescent , Antibodies, Protozoan/blood , Female , Humans , Macula Lutea/parasitology , Polymerase Chain Reaction , Retinal Diseases/parasitology , Toxoplasma/genetics , Toxoplasma/immunology , Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis, Ocular/blood , Visual Acuity/physiology
7.
Eur J Anaesthesiol ; 16(3): 201-3, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10225171

ABSTRACT

We report a case of surgical transsection of the nasoendotracheal tube during a Lefort I maxillary osteotomy, resulting in severe intra-operative ventilatory difficulties. The management of this problem and a brief review of the literature are presented.


Subject(s)
Anesthesia/adverse effects , Cleft Palate/surgery , Intraoperative Complications/physiopathology , Maxilla/surgery , Osteotomy/adverse effects , Adolescent , Equipment Failure , Female , Humans , Intraoperative Complications/etiology , Intubation, Intratracheal/instrumentation , Osteotomy/instrumentation , Respiratory Mechanics
SELECTION OF CITATIONS
SEARCH DETAIL